Efficacy and Safety of Tocilizumab Treatment COVID-19 Patients: A Case-Control Study and Meta-Analysis

INTRODUCTION: As the pandemic progresses, the pathophysiology of COVID-19 is becoming more apparent, and the potential for tocilizumab is increasing. However, the clinical efficacy and safety of tocilizumab in the treatment of COVID-19 patients remain unclear. METHODS: To assess the efficacy and saf...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Weijun, Li, Weiwei, Wu, Qiuyue, Han, Ying, Zhang, Jing, Luo, Tao, Guo, Yanju, Yang, Yang, Zhu, Peiran, Xia, Xinyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269405/
https://www.ncbi.nlm.nih.gov/pubmed/34244956
http://dx.doi.org/10.1007/s40121-021-00483-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269405/
https://www.ncbi.nlm.nih.gov/pubmed/34244956
http://dx.doi.org/10.1007/s40121-021-00483-x

Ejemplares similares